{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:43:20Z","timestamp":1762854200258,"version":"build-2065373602"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.gofs.2020.01.013","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:41:37Z","timestamp":1580229697000},"page":"248-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF \u2014\u00a0\u00c9pid\u00e9miologie et facteurs de risques de r\u00e9cidive, modalit\u00e9s de surveillance et int\u00e9r\u00eat d\u2019une chirurgie de cl\u00f4ture"],"prefix":"10.1016","volume":"48","author":[{"given":"F.","family":"Margueritte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sallee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lacorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gauroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Larouzee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"De La Motte Rouge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"M\u00e9thode recommandations pour la pratique clinique \u2014\u00a0\u00c9laboration de recommandations de bonne pratique\u00a0\u2014 Fiche m\u00e9thodologique de la HAS d\u00e9cembre 2010","key":"10.1016\/j.gofs.2020.01.013_bib0380"},{"year":"2010","series-title":"R\u00e9daction de l\u2019argumentaire scientifique \u2014\u00a0\u00c9laboration de recommandations de bonne pratique et des recommandations\u00a0\u2014 Fiche m\u00e9thodologique de la HAS d\u00e9cembre 2010","key":"10.1016\/j.gofs.2020.01.013_bib0385"},{"key":"10.1016\/j.gofs.2020.01.013_bib0390","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1525-1438.2007.01051.x","article-title":"Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period","volume":"18","author":"Akeson","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2019.01.021","article-title":"Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery","volume":"111","author":"Delle Marchette","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0400","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/1097-0142(19861101)58:9<2052::AID-CNCR2820580916>3.0.CO;2-5","article-title":"Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109\u00a0cases","volume":"58","author":"Bostwick","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0405","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0410","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejca.2015.01.004","article-title":"Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk","volume":"51","author":"Vasconcelos","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0415","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/humupd\/dms047","article-title":"Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options","volume":"19","author":"Dara\u00ef","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.gofs.2020.01.013_bib0420","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2015.11.005","article-title":"Impact of surgical staging on prognosis in patients with borderline ovarian tumours: a meta-analysis","volume":"54","author":"Shim","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0425","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1471-0528.14577","article-title":"Improving the clinical management of women with borderline tumours: a recurrence risk scoring system from a French multicentre study","volume":"124","author":"Ouldamer","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2020.01.013_bib0430","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.fertnstert.2004.10.009","article-title":"Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study","volume":"83","author":"Fauvet","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2020.01.013_bib0435","doi-asserted-by":"crossref","unstructured":"Gauroy E, Larouzee E, Chereau E, Rouge TDLM, Margueritte F, Sallee C, et al. [Borderline Ovarian Tumours: CNGOF Guidelines for clinical practice -Diagnosis and management of recurrent borderline ovarian tumors]. Gynecol Obstet Fertil Senol 2020. https:\/\/doi.org\/10.1016\/j.gofs.2020.01.019","DOI":"10.1016\/j.gofs.2020.01.019"},{"key":"10.1016\/j.gofs.2020.01.013_bib0440","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group","volume":"49","author":"du Bois","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0445","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/annonc\/mdu119","article-title":"Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study","volume":"25","author":"Trillsch","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0450","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/IGC.0000000000000476","article-title":"The value of serum CA125\u00a0in the diagnosis of borderline tumors of the ovary: a subanalysis of the prospective multicenter ROBOT study","volume":"25","author":"Fotopoulou","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0455","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/IGC.0000000000000722","article-title":"The evaluation of risk factors associated with relapse and recurrence of borderline ovarian tumors with long-term follow-up","volume":"26","author":"Sobiczewski","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0460","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/aogs.13203","article-title":"Fertility preservation in women with borderline ovarian tumors \u2013 how does it impact disease outcome? A cohort study","volume":"96","author":"Helpman","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gofs.2020.01.013_bib0465","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0470","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/cncr.20080","article-title":"Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis","volume":"100","author":"Sherman","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0475","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/0284186X.2019.1619935","article-title":"Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis","volume":"58","author":"Schuurman","year":"2019","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.gofs.2020.01.013_bib0480","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2016.05.005","article-title":"Relapse and disease specific survival in 1143\u00a0Danish women diagnosed with borderline ovarian tumours (BOT)","volume":"142","author":"Karlsen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0485","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/annonc\/mdq414","article-title":"How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II\u2013III serous borderline tumours of the ovary","volume":"22","author":"Uzan","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0490","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2009.05.018","article-title":"Prognostic factors predicting recurrence in borderline ovarian tumors","volume":"114","author":"Wu","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0495","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0500","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bpobgyn.2016.09.012","article-title":"Management of borderline ovarian tumours","volume":"41","author":"Gershenson","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0505","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1186\/s12885-018-4932-2","article-title":"The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (\u226440\u00a0years old) with borderline ovarian tumors","volume":"18","author":"Fang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0510","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/IGC.0000000000000216","article-title":"Risk factors for progression to invasive carcinoma in patients with borderline ovarian tumors","volume":"24","author":"Song","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0515","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13048-018-0423-y","article-title":"Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors","volume":"11","author":"Sun","year":"2018","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.gofs.2020.01.013_bib0520","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1098-2388(200007\/08)19:1<69::AID-SSU11>3.0.CO;2-E","article-title":"Surgery for borderline tumor of the ovary","volume":"19","author":"Trop\u00e9","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0525","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/IGC.0b013e31827b8844","article-title":"Nomogram to predict the probability of relapse in patients diagnosed with borderline ovarian tumors","volume":"23","author":"Obermair","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0530","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1186\/s12885-018-5091-1","article-title":"Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours","volume":"18","author":"Jia","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0535","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2016.11.007","article-title":"A nationwide study of ovarian serous borderline tumors in Denmark 1978\u20132002. Risk of recurrence, and development of ovarian serous carcinoma","volume":"144","author":"Hannibal","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0540","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/IGC.0000000000001092","article-title":"Prognostic factors for recurrence after fertility-preserving surgery in patients with borderline ovarian tumors: a systematic review and meta-analysis of observational studies","volume":"27","author":"Jiao","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0545","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/humrep\/deq159","article-title":"Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2020.01.013_bib0550","doi-asserted-by":"crossref","unstructured":"Canlorbe G, Lecointre L, Chauvet P, Aza\u00efs H, Fauvet R, Uzan C. Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF\u2013Prise en charge th\u00e9rapeutique des stades pr\u00e9coces. Gyn\u00e9cologie Obst\u00e9trique Fertil S\u00e9nologie 2020. https:\/\/doi.org\/10.1016\/j.gofs.2020.01.016","DOI":"10.1016\/j.gofs.2020.01.016"},{"key":"10.1016\/j.gofs.2020.01.013_bib0555","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1245\/s10434-010-1293-8","article-title":"Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma)","volume":"18","author":"Koskas","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0560","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ygyno.2006.05.022","article-title":"Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?","volume":"103","author":"Cho","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0565","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1245\/s10434-011-2039-y","article-title":"Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study","volume":"19","author":"Fauvet","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0570","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1634\/theoncologist.2008-0263","article-title":"Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants","volume":"14","author":"Kane","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.gofs.2020.01.013_bib0575","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mdu139","article-title":"Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191\u00a0conservative treatments","volume":"25","author":"Uzan","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0580","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2011.08.008","article-title":"Micropapillary pattern in serous borderline ovarian tumors: does it matter?","volume":"123","author":"Park","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0585","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2010.11.016","article-title":"Risk factors for recurrence of ovarian borderline tumors","volume":"120","author":"Shih","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0590","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ygyno.2006.10.001","article-title":"Results of the national survey of borderline ovarian tumors in Spain","volume":"104","author":"Cusid\u00f3","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0595","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/IGC.0000000000001154","article-title":"Clinical predictors of recurrence and prognostic value of lymph node involvement in the serous borderline ovarian tumor","volume":"28","author":"Qian","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0600","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/1471-0528.13840","article-title":"Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates","volume":"123","author":"Vasconcelos","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2020.01.013_bib0605","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/annonc\/mdi083","article-title":"Laparoscopic management of borderline ovarian tumors: results of a French multicenter study","volume":"16","author":"Fauvet","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0610","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/00016340701286934","article-title":"Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy","volume":"86","author":"\u00d8degaard","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gofs.2020.01.013_bib0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.12.055","article-title":"Prognostic value of lymph node involvement in ovarian serous borderline tumors","volume":"204","author":"Lesieur","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0620","first-page":"5609","article-title":"The impact of surgical staging on the prognosis of mucinous borderline tumors of the ovaries: a multicenter study","volume":"37","author":"Gungorduk","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.gofs.2020.01.013_bib0625","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2013.08.038","article-title":"Effect of surgical staging on 539\u00a0patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study","volume":"131","author":"Guvenal","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0630","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejogrb.2009.04.031","article-title":"Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort","volume":"145","author":"Lenhard","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0635","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00404-010-1539-5","article-title":"Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?","volume":"283","author":"Kanat-Pektas","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gofs.2020.01.013_bib0640","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/01443615.2018.1499076","article-title":"Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution","volume":"39","author":"Sozen","year":"2019","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0645","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2017.01.019","article-title":"Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors","volume":"144","author":"Matsuo","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3181c0a5ab","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases","volume":"34","author":"Djordjevic","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0655","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13048-017-0316-5","article-title":"Identification of factors that impact recurrence in patients with borderline ovarian tumors","volume":"10","author":"Chen","year":"2017","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.gofs.2020.01.013_bib0660","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2017.03.019","article-title":"Minimally invasive compared with open surgery in patients with borderline ovarian tumors","volume":"145","author":"Song","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0665","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1515\/CCLM.2009.134","article-title":"Predictive value of CA 125\u00a0and CA 72-4\u00a0in ovarian borderline tumors","volume":"47","author":"Lenhard","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.gofs.2020.01.013_bib0670","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000475817","article-title":"Elevated preoperative CA125\u00a0or CA19-9\u00a0in borderline ovarian tumors: could it be suggestive of advanced stage or a poor prognosis?","volume":"83","author":"Song","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.gofs.2020.01.013_bib0675","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/bjc.2013.678","article-title":"External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours","volume":"109","author":"Bendifallah","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.06.028","article-title":"Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors","volume":"211","author":"Bendifallah","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0685","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bulcan.2017.06.016","article-title":"External multicentric validation of two scores predicting the risk of relapse in patients with borderline ovarian tumors: the nomogram of Bendifallah and the score of ouldamer","volume":"104","author":"Pais","year":"2017","journal-title":"Bull Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0690","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000360990","article-title":"High-risk borderline ovarian tumors: analysis of clinicopathological features and prognostic impact of different follow-up strategies","volume":"87","author":"Lorusso","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.gofs.2020.01.013_bib0695","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/annonc\/mdt430","article-title":"Prognostic factors for recurrence after conservative treatment in a series of 119\u00a0patients with stage I serous borderline tumors of the ovary","volume":"25","author":"Uzan","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0700","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/gyno.2000.6099","article-title":"Ultrasound, physical examination, and CA 125\u00a0measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors","volume":"81","author":"Zanetta","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0705","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ygyno.2008.03.019","article-title":"A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors","volume":"110","author":"Ren","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0710","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/IGC.0b013e31825e5254","article-title":"Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management","volume":"22","author":"Ferrero","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0715","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2008.12.034","article-title":"Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery","volume":"113","author":"Park","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0720","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/IGC.0b013e31824b4076","article-title":"Prognosis in patients with serous and mucinous stage I borderline ovarian tumors","volume":"22","author":"Song","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0725","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/IGC.0000000000001170","article-title":"Short-term outcomes and pregnancy rate after laparoscopic fertility-sparing surgery for borderline ovarian tumors: a single-institute experience","volume":"28","author":"Zhao","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.01.013_bib0730","doi-asserted-by":"crossref","first-page":"115718","DOI":"10.18632\/oncotarget.23021","article-title":"The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors","volume":"8","author":"Lou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gofs.2020.01.013_bib0735","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/humrep\/del381","article-title":"Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study","volume":"22","author":"Palomba","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2020.01.013_bib0740","first-page":"118","article-title":"Recurrence of borderline ovarian tumors","volume":"35","author":"Svintsitskiy","year":"2013","journal-title":"Exp Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0745","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejso.2010.07.004","article-title":"Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study","volume":"36","author":"Poncelet","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gofs.2020.01.013_bib0750","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/uog.12276","article-title":"Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors","volume":"41","author":"Franchi","year":"2013","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:39:30Z","timestamp":1762853970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718920300337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2468718920300337"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.013","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF \u2014\u00a0\u00c9pid\u00e9miologie et facteurs de risques de r\u00e9cidive, modalit\u00e9s de surveillance et int\u00e9r\u00eat d\u2019une chirurgie de cl\u00f4ture","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}